FED-F is a modular treatment that enhances exposure therapy with psychoeducation and cognitive skills teaching how to face fears of (a) food, (b) weight gain, (c) interoception/body, and (d) social situations. The study goals are to (1) refine and test the acceptability and feasibility of FED-F treatment (Phase I), (2) test if this treatment outperforms treatment as usual (TAU) delivered post-acute treatment as adjunctive to stepdown specialty care (Phase II), and (3) to examine if treatment targets the hypothesized mechanism of action: approach behaviors (Phase II). These goals will lead to a highly deployable and accessible virtual treatment targeted at core AN mechanisms that predict relapse. Specific aims are to (1) refine FED-F into a fully virtual format with input from patients and stakeholders and collect preliminary data (N=10) on its feasibility and acceptability (Phase I), (2) conduct a small pilot RCT (randomized controlled trial) of FED-F (n=30) as compared to TAU (n=30; Phase II), and (3) examine if FED-F targets approach/avoidance behaviors and test if this mechanism is associated with clinical outcomes (Phase II).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Structured Clinical Interview for DSM-5 (SCID-5)
Timeframe: Up to 2-month follow-up
Change in Eating Disorder Fear Inventory (EFI)
Timeframe: Up to 2-month follow-up
Change in Treatment Interview
Timeframe: Up to 2-month follow-up
Change in Eating Disorder Examination Questionnaire 6.0 (EDE-Q)
Timeframe: Up to 2-month follow-up
Change in Fear of Food Measure (FOFM)
Timeframe: Up to 2-month follow-up
Change in Eating Disorder Fear Questionnaire (EFQ)
Timeframe: Up to 2-month follow-up